Raphael Bueno Selected Research

1-methyl-1-piperidinomethane sulfonate

5/2013	Sequential binary gene ratio tests define a novel molecular diagnostic strategy for malignant pleural mesothelioma.
3/2012	Expression of interleukin-4 receptor alpha in human pleural mesothelioma is associated with poor survival and promotion of tumor inflammation.
8/2008	Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma.
3/2008	Transcriptome sequencing of malignant pleural mesothelioma tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raphael Bueno Research Topics

Disease

98	Neoplasms (Cancer) 01/2022 - 05/2002
42	Mesothelioma 10/2022 - 05/2002
41	Malignant Mesothelioma 04/2021 - 05/2002
21	Lung Neoplasms (Lung Cancer) 12/2021 - 02/2004
19	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 02/2003
8	Adenocarcinoma 01/2021 - 12/2003
7	Chronic Obstructive Pulmonary Disease (COPD) 12/2021 - 03/2009
6	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 01/2013
5	Neoplasm Metastasis (Metastasis) 04/2014 - 02/2003
4	Inflammation (Inflammations) 12/2021 - 03/2012
4	Carcinoma (Carcinomatosis) 01/2019 - 11/2011
4	Adenocarcinoma of Lung 02/2016 - 09/2003
3	Infections 01/2022 - 07/2004
3	Pneumonia (Pneumonitis) 01/2021 - 07/2006
3	Heart Arrest (Cardiac Arrest) 04/2008 - 07/2004
2	Empyema 10/2022 - 07/2004
2	Emphysema 02/2021 - 03/2009
2	Fistula 01/2021 - 07/2004
2	Adenocarcinoma in Situ 01/2021 - 12/2017
2	Hyperplasia 01/2021 - 12/2017
2	Pathologic Constriction (Stenosis) 01/2021 - 05/2003
2	Embolism (Embolus) 10/2020 - 07/2004
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2020 - 07/2004
2	Lung Diseases (Lung Disease) 03/2017 - 02/2006
2	Pulmonary Edema 06/2014 - 06/2008
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2013 - 07/2004
2	Sepsis (Septicemia) 12/2013 - 02/2007
2	Disease Progression 10/2010 - 08/2008
2	Hemorrhage 05/2009 - 07/2004
2	Dyspnea (Shortness of Breath) 02/2007 - 12/2002
2	Melanoma (Melanoma, Malignant) 09/2003 - 02/2003
2	Carcinogenesis 06/2002 - 05/2002
1	Pleural Empyema (Pyothorax) 10/2022
1	Bites and Stings (Sting) 01/2022
1	Margins of Excision 01/2022
1	COVID-19 01/2022
1	Esophageal Squamous Cell Carcinoma 12/2021
1	Foreign Bodies (Foreign Body) 12/2021

Drug/Important Bio-Agent (IBA)

14	AsbestosIBA 02/2021 - 07/2002
13	Proteins (Proteins, Gene)FDA Link 10/2022 - 06/2002
12	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 06/2002
10	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2003
10	Messenger RNA (mRNA)IBA 01/2021 - 06/2002
7	Biomarkers (Surrogate Marker)IBA 12/2021 - 03/2009
5	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2016
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2002
4	1-methyl-1-piperidinomethane sulfonateIBA 05/2013 - 03/2008
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2012 - 02/2004
3	B7-H1 AntigenIBA 01/2020 - 02/2016
3	CytokinesIBA 01/2018 - 03/2012
3	Gemcitabine FDA Link 01/2018 - 11/2008
3	Formaldehyde (Formol)FDA Link 01/2017 - 01/2015
3	SuspensionsIBA 12/2016 - 02/2003
3	Bortezomib (Velcade)FDA Link 01/2016 - 04/2008
2	Neurofibromin 2 (Merlin)IBA 10/2022 - 10/2016
2	MesothelinIBA 01/2022 - 08/2011
2	Keratins (Keratin)IBA 12/2021 - 11/2008
2	Small Cytoplasmic RNAIBA 01/2020 - 01/2019
2	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2020 - 07/2002
2	HMGB1 Protein (HMG1)IBA 10/2019 - 01/2017
2	AntibodiesIBA 01/2018 - 02/2016
2	ParaffinIBA 01/2017 - 01/2015
2	Transcription Factors (Transcription Factor)IBA 10/2016 - 03/2016
2	Small Interfering RNA (siRNA)IBA 01/2016 - 11/2008
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2016 - 01/2013
2	Pemetrexed (MTA)FDA Link 01/2016 - 04/2008
2	1- (4- ((2- (2- aminopyrimidin- 5- yl)- 7- methyl- 4- morpholinothieno(3,2- d)pyrimidin- 6- yl)methyl)piperazin- 1- yl)- 2- hydroxypropan- 1- oneIBA 01/2015 - 01/2014
2	MTOR InhibitorsIBA 01/2014 - 11/2008
2	Hemoglobins (Hemoglobin)IBA 04/2013 - 02/2012
2	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 03/2012 - 11/2011
2	ErbB Receptors (EGF Receptor)IBA 01/2011 - 01/2008
2	Oxygen (Dioxygen)IBA 02/2006 - 06/2005
2	OligonucleotidesIBA 06/2005 - 06/2005
2	Collagen Type IV (Type IV Collagen)IBA 04/2005 - 08/2004
2	Biological ProductsIBA 11/2004 - 09/2003
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2003 - 02/2003
1	InterferonsIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	ChemokinesIBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 12/2021

Therapy/Procedure

39	Therapeutics 01/2022 - 05/2003
20	Pneumonectomy (Lung Volume Reduction) 11/2021 - 12/2002
20	Drug Therapy (Chemotherapy) 04/2021 - 03/2005
9	Neoadjuvant Therapy 10/2022 - 03/2005
9	Radiotherapy 01/2019 - 07/2006
6	Immunotherapy 01/2019 - 01/2016
5	Esophagectomy 01/2022 - 01/2015
4	Adjuvant Chemotherapy 01/2022 - 07/2006
4	Cytoreduction Surgical Procedures 04/2021 - 05/2009
3	Length of Stay 10/2022 - 04/2021
3	Thoracotomy 01/2016 - 02/2004
2	Operative Time 04/2021 - 02/2007
2	Catheters 01/2020 - 07/2004
2	Operative Surgical Procedures 01/2019 - 03/2010
2	Pericardiectomy 11/2018 - 04/2008
2	Chemoradiotherapy 01/2015 - 03/2008
2	Aftercare (After-Treatment) 09/2009 - 07/2006
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 06/2007 - 04/2004
2	Mechanical Ventilators (Ventilator) 02/2007 - 06/2005
1	Lymph Node Excision (Lymph Node Dissection) 01/2022